Revon Systems And Humana Team Up For Smart Symptom Tracker Program

LOUISVILLE, Ky., Oct. 27, 2017 /PRNewswire/ -- Revon Systems, a Kentucky digital health company, is partnering with Humana, on a market-wide pilot for a select population of Medicare Advantage members diagnosed with chronic obstructive pulmonary disease (COPD). The program involves the use of the Revon Smart Symptom Tracker (RSST) mobile application and the free Breathe COPD Resource Kit, which contains a pulse oximeter and thermometer. The RSST application features a self-triage function intended to guide members toward the right level of care. The program seeks to evaluate the impact of digital therapies on clinical and business outcomes. Recommendations from the RSST guide users to take the appropriate early action on the basis of their symptoms, signs, and personal baseline health.

Ted Smith, Ph.D., and Chief Executive Officer of Revon Systems stated "We are pleased to work with Humana on their Bold Goal to reduce chronic disease by 20% by 2020. We know that COPD can be a challenge for patients to manage, and we hope that Revon's Smart Symptom Tracker technology will result in more Healthy Days for the participating members" 

About Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD) is a chronic lung condition and the third leading cause of death in the United States. 10.3% of Kentucky residents report having a COPD diagnosis. COPD, once deemed to be a disease with a hopeless prognosis, is now known to be very treatable. Early diagnosis and treatment can enable people with COPD to take charge of their breathing and regain control of their lives. Common treatment goals include becoming more active, decreasing shortness of breath, and lowering of anxiety and depression.

About REVON Systems

Revon  Systems, Inc. is a Kentucky-based digital therapeutics company founded in 2013 by a group of entrepreneurs in the biotechnology industry. The company has developed smart symptom tracking technology in asthma and COPD. Revon believes that early  intelligent interpretation and feedback of data to patients leads to better control of chronic diseases that "flare up" or exacerbate such as COPD, Asthma and many others. Website: www.revon.ai

For more details about this program, please contact Revon Systems, Inc. at 502-398-6511 or email [email protected].

SOURCE Revon Systems

Related Links

https://revon.ai